BPC-157 (Pentadecapeptide)

BPC-157 Peptide: Structure and Sequence

Reviewed by our laboratory team · Last updated 2026-07-03

BPC-157 has the amino acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV). It is a linear 15-residue synthetic peptide unusually rich in proline residues, which is thought to contribute to its resistance to enzymatic degradation.

Key facts

Full sequence
GEPPPGKPADDAGLV
Residues
15
Proline content
4 residues (~27%)
MW
~1,419 Da

Why so many prolines?

Proline restricts backbone conformation and disrupts protease recognition. BPC-157's proline-rich core is a leading hypothesis for the peptide's reported stability in acidic and enzymatic environments.

Extended research context

The BPC-157 (Pentadecapeptide) deep dive

Deep dive: the pentadecapeptide sequence

BPC-157 is a synthetic pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is derived from a fragment identified in human gastric juice by the Zagreb research group (Sikirić and colleagues), whose body of published work spans three decades and covers models ranging from tendon repair to gut integrity. The 'BPC' initials stand for 'body protection compound' — the group's original characterisation term.

Two forms: acetate salt vs arginate

BPC-157 is supplied most commonly as an acetate salt; a small subset of suppliers offer the arginate form, which has slightly different solubility and stability properties. For research reproducibility, keep the salt form consistent across a study and confirm which form the CoA specifies (mass ± counterion changes the reading).

Reading a BPC-157 CoA

A trustworthy BPC-157 CoA lists HPLC purity (target ≥98% area), mass-spec confirmation (~1,419 Da for the free peptide), water content (Karl Fischer), acetate content, and residual solvents. Some batches also include endotoxin data. Any missing category is a red flag for a compromised supply chain.

Research applications

  • Cell-culture models of gut epithelial integrity
  • Tendon fibroblast migration and collagen-synthesis assays
  • Angiogenesis models involving VEGF and NO signalling
  • Stability studies comparing acetate vs arginate salt forms
  • Analytical reference for pentadecapeptide HPLC methods

Handling checklist

  • Store lyophilised vial at −20 °C long-term (2–8 °C short-term)
  • Reconstitute with bacteriostatic water; a 5 mg vial dissolves cleanly
  • Aliquot reconstituted solution; keep refrigerated 2–8 °C, use within 28 days
  • Protect from light and repeated warming
  • Verify CoA: HPLC ≥98%, mass ~1,419 Da, salt form declared

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

Mixing acetate and arginate BPC-157 across a study

Fix: Choose one salt form and stay with it — different masses and solubility.

Assuming stability at room temperature

Fix: Refrigerate reconstituted solution; discard after 28 days.

Buying without a CoA

Fix: Only source from suppliers that publish batch HPLC + mass-spec data.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Related questions researchers ask

  • What does BPC-157 stand for?
  • Is BPC-157 the same as pentadecapeptide?
  • Who discovered BPC-157?
  • What is the difference between BPC-157 acetate and arginate?
  • How is BPC-157 reconstituted for research?

Frequently asked questions

Is the sequence patented?
The BPC-157 sequence is disclosed in Sikiric et al. publications.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab (external, rel="nofollow").

More BPC-157 (Pentadecapeptide) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.